To regain its position as a leader in advanced manufacturing, America must strengthen its intellectual property (IP) protections, similar to the successful biopharmaceutical sector. By maintaining robust patents, the nation can foster innovation and attract investments in manufacturing facilities and advanced processes. The biotech industry exemplifies this strategy, utilizing modern techniques like continuous bioprocessing to enhance production efficiency significantly. This approach can help the U.S. outcompete countries with lower labor costs by promoting high-value manufacturing jobs and resilient supply chains essential for national security.
Maintaining and strengthening IP protections will ensure that the products of the future aren't merely designed in America, but also made in America.
Revitalizing American manufacturing won't be easy. But it's possible if our leaders look to the biotech sector-one of the global industries that we still unquestionably dominate.
A key lesson from biotech? Patents and other IP protections are essential. They don't merely drive the R&D investment that leads to new inventions like drugs and medical devices.
This breakthrough-made possible by patented bioreactors and automation systems-significantly reduces downtime, space requirements and costs.
Collection
[
|
...
]